Donald F. Grabarz is a co-founder and Managing Director of International Regulatory Consultants, a Limited Liability Company, established in 1989. He was the founder and is President of DFG & ASSOCIATES, Inc., Salt Lake City, Utah, a consulting practice established in 1986 dedicated towards serving manufacturers of medical devices and related products on regulatory and quality matters. Mr. Grabarz is a Pharmacist by profession having received his degree from St. John’s University in New York City.  He has also studied at Pace University and attended courses provided by the Wharton School of Business.  Prior to establishing DFG & ASSOCIATES, Mr. Grabarz has had over twenty years of industry experience with significant management responsibilities in major corporations such as Johnson & Johnson, Becton Dickinson, C.R. BARD and Symbion.

Having had extensive and intimate involvement in the evolution of the Medical Device Amendments to the US Federal Food, Drug, and Cosmetic Act, as well as being active in the development of Safe Medical Devices Act, and those implementing regulations, Mr. Grabarz has lectured extensively throughout the U.S. and Europe on a variety of related subjects.  He has conducted seminars and lectures on regulatory and quality matters for such organizations as HIMA (Advamed), RAPS, the Institute for Applied Technology, the Center for Professional Advancement, Pharmaceutical Training Institute and St. John’s University.  He has provided his expertise in conferences sponsored by Ernst & Young and Adams, Harkness & Hill.  Mr. Grabarz was instrumental in the development and conduct of a course on Regulation and Marketing of Medical Devices at Fairleigh Dickinson University in their Pharmaceutical MBA Program and is an adjunct professor in curriculum development as well as teaching GMP and Regulatory Affairs Management at Salt Lake Community College.